Literature DB >> 17075824

Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells.

Lamia Benbrahim-Tallaa1, Jie Liu, Mukta M Webber, Michael P Waalkes.   

Abstract

BACKGROUND: Lethal prostate cancers often become androgen-independent due to androgen receptor (AR) overexpression. The role of cadmium in prostate tumor progression was determined.
METHODS: Control and cadmium-transformed prostate epithelial cells (CTPE) were compared for steroid-induced proliferation, steroid receptor expression, and androgen metabolism.
RESULTS: CTPE cells showed rapid proliferation in complete medium and sustained proliferation in steroid-reduced medium. Androgens stimulated significantly less cell proliferation and AR-related genes expression in CTPE cells. 5alpha-Dihydrotestosterone increased PSA expression more effectively in control cells. Flutamide reduced 5alpha-dihydrotestosterone-stimulated growth less effectively in CTPE cells compared to control. CTPE cells showed decreased p27 expression. Estrogen receptors were overexpressed and estradiol markedly stimulated proliferation in CTPE cells. In CTPE cells 5alpha-aromatase was markedly increased, while 5alpha-reductase was decreased.
CONCLUSIONS: Cadmium-induced malignant transformation stimulates androgen independence, unrelated to AR expression or activity. Increased estrogen receptor and 5alpha-aromatase expression suggest estrogen signaling may be critical to this process. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17075824     DOI: 10.1002/pros.20479

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  17 in total

1.  Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer.

Authors:  Lin Yang; Preethi Ravindranathan; Meera Ramanan; Payal Kapur; Stephen R Hammes; Jer-Tsong Hsieh; Ganesh V Raj
Journal:  Mol Endocrinol       Date:  2012-03-08

Review 2.  Metals and Mechanisms of Carcinogenesis.

Authors:  Qiao Yi Chen; Thomas DesMarais; Max Costa
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

3.  Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells.

Authors:  Yi Jing; Ling-Zhi Liu; Yue Jiang; Yingxue Zhu; Nancy Lan Guo; John Barnett; Yon Rojanasakul; Faton Agani; Bing-Hua Jiang
Journal:  Toxicol Sci       Date:  2011-10-09       Impact factor: 4.849

Review 4.  Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.

Authors:  Wen-Yang Hu; Guang-Bin Shi; Dan-Ping Hu; Jason L Nelles; Gail S Prins
Journal:  Mol Cell Endocrinol       Date:  2011-09-05       Impact factor: 4.102

5.  Smoking and prostate cancer survival and recurrence.

Authors:  Stacey A Kenfield; Meir J Stampfer; June M Chan; Edward Giovannucci
Journal:  JAMA       Date:  2011-06-22       Impact factor: 56.272

6.  Predicting environmental chemical factors associated with disease-related gene expression data.

Authors:  Chirag J Patel; Atul J Butte
Journal:  BMC Med Genomics       Date:  2010-05-06       Impact factor: 3.063

Review 7.  Endocrine disruptors and prostate cancer risk.

Authors:  Gail S Prins
Journal:  Endocr Relat Cancer       Date:  2008-06-04       Impact factor: 5.678

8.  Chronic cadmium exposure in vitro induces cancer cell characteristics in human lung cells.

Authors:  Rachel J Person; Erik J Tokar; Yuanyuan Xu; Ruben Orihuela; Ntube N Olive Ngalame; Michael P Waalkes
Journal:  Toxicol Appl Pharmacol       Date:  2013-06-26       Impact factor: 4.219

Review 9.  Cadmium as a possible cause of bladder cancer: a review of accumulated evidence.

Authors:  Molka Feki-Tounsi; Amel Hamza-Chaffai
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-04       Impact factor: 4.223

Review 10.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement.

Authors:  Evanthia Diamanti-Kandarakis; Jean-Pierre Bourguignon; Linda C Giudice; Russ Hauser; Gail S Prins; Ana M Soto; R Thomas Zoeller; Andrea C Gore
Journal:  Endocr Rev       Date:  2009-06       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.